Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Raymond

Showing results (521-530 of 1,063) with videos related to

Pageof 107
Sort By:
Journal of Medicinal Chemistry|June 21, 2023
Correction to "Discovery of a Thiadiazole-Pyridazine-Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft Models"M Raymond V Finlay, Mark Anderton, Andrew Bailey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2020
Preclinical Comparison of the Blood-brain barrier Permeability of Osimertinib with Other EGFR TKIsNicola Colclough, Kan Chen, Peter Johnström, et al.
JAMA|September 2, 2015
Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in YouthRajen J Mody, Yi-Mi Wu, Robert J Lonigro, et al.
Journal of Medicinal Chemistry|October 2, 2014
Discovery of a potent and selective EGFR inhibitor (AZD9291) of both sensitizing and T790M resistance mutations that spares the wild type form of the receptorM Raymond V Finlay, Mark Anderton, Susan Ashton, et al.
Journal of Medical Genetics|July 5, 2022
Clinical, biochemical and genetic characteristics of MOGS-CDG: a rare congenital disorder of glycosylationShino Shimada, Bobby G Ng, Amy L White, et al.
American Journal of Human Genetics|June 17, 2014
PGM3 mutations cause a congenital disorder of glycosylation with severe immunodeficiency and skeletal dysplasiaAsbjørg Stray-Pedersen, Paul H Backe, Hanne S Sorte, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2021
Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal CancerAparna R Parikh, Emily E Van Seventer, Giulia Siravegna, et al.
The European Physical Journal. C, Particles and Fields|April 9, 2019
Study of inelastic nuclear interactions of 400 GeV/c protons in bent silicon crystals for beam steering purposesW Scandale, F Andrisani, G Arduini, et al.
American Journal of Human Genetics|October 6, 2018
A Recurrent De Novo Heterozygous COG4 Substitution Leads to Saul-Wilson Syndrome, Disrupted Vesicular Trafficking, and Altered Proteoglycan GlycosylationCarlos R Ferreira, Zhi-Jie Xia, Aurélie Clément, et al.
Nature|August 9, 2023
Diverse values of nature for sustainabilityUnai Pascual, Patricia Balvanera, Christopher B Anderson, et al.
Pageof 107

Showing results (521-530 of 1,063) with videos related to

Sort By:
Pageof 107
Journal of Medicinal Chemistry|June 21, 2023
Correction to "Discovery of a Thiadiazole-Pyridazine-Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft Models"M Raymond V Finlay, Mark Anderton, Andrew Bailey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2020
Preclinical Comparison of the Blood-brain barrier Permeability of Osimertinib with Other EGFR TKIsNicola Colclough, Kan Chen, Peter Johnström, et al.
JAMA|September 2, 2015
Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in YouthRajen J Mody, Yi-Mi Wu, Robert J Lonigro, et al.
Journal of Medicinal Chemistry|October 2, 2014
Discovery of a potent and selective EGFR inhibitor (AZD9291) of both sensitizing and T790M resistance mutations that spares the wild type form of the receptorM Raymond V Finlay, Mark Anderton, Susan Ashton, et al.
Journal of Medical Genetics|July 5, 2022
Clinical, biochemical and genetic characteristics of MOGS-CDG: a rare congenital disorder of glycosylationShino Shimada, Bobby G Ng, Amy L White, et al.
American Journal of Human Genetics|June 17, 2014
PGM3 mutations cause a congenital disorder of glycosylation with severe immunodeficiency and skeletal dysplasiaAsbjørg Stray-Pedersen, Paul H Backe, Hanne S Sorte, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2021
Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal CancerAparna R Parikh, Emily E Van Seventer, Giulia Siravegna, et al.
The European Physical Journal. C, Particles and Fields|April 9, 2019
Study of inelastic nuclear interactions of 400 GeV/c protons in bent silicon crystals for beam steering purposesW Scandale, F Andrisani, G Arduini, et al.
American Journal of Human Genetics|October 6, 2018
A Recurrent De Novo Heterozygous COG4 Substitution Leads to Saul-Wilson Syndrome, Disrupted Vesicular Trafficking, and Altered Proteoglycan GlycosylationCarlos R Ferreira, Zhi-Jie Xia, Aurélie Clément, et al.
Nature|August 9, 2023
Diverse values of nature for sustainabilityUnai Pascual, Patricia Balvanera, Christopher B Anderson, et al.
Pageof 107